Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.71
-0.41 (-5.76%)
At close: Jul 18, 2025, 4:00 PM
6.84
+0.13 (1.94%)
After-hours: Jul 18, 2025, 6:50 PM EDT
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $416.05 million as of July 18, 2025. Its market cap has increased by 17.45% in one year.
Market Cap
416.05M
Enterprise Value
306.50M
1-Year Change
17.45%
Ranking
Category
Stock Price
$6.71
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has increased from $397.73M to $416.05M, an increase of 4.60%. That is a compound annual growth rate of 1.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 416.05M | 1.33% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.79B |
| Johnson & Johnson | 393.87B |
| AbbVie | 334.31B |
| Novo Nordisk | 287.38B |
| UnitedHealth Group | 256.40B |
| Novartis AG | 223.49B |
| Abbott Laboratories | 215.17B |
| AstraZeneca | 214.61B |